The Global Anticoccidial Drugs Market Growth

The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030, resulting in a market growth of USD 1691.94 million by 2028.

Market Share Insights

Based on the Drug type, the ionophore anticoccidials segment had the largest market share of the global anticoccidial drugs market in 2022.

Based on animal type, the poultry animal segment had the largest market share of the global anticoccidial drugs market in 2022.

Impact of COVID-19 on the Market

The COVID-19 pandemic has impacted the global anticoccidial drugs market by increasing the demand for drugs to prevent and treat coccidiosis in animals.

Market Drivers

The growth in the prevalence of coccidiosis and the increasing focus on animal health are primary drivers accelerating the global anticoccidial drugs market.

Market Restraints

The need for skilled personnel in manufacturing appropriate drugs and the availability of lower-cost alternatives restrict the growth of the global anticoccidial drugs market.

By Drug Type

The ionophore anticoccidials segment witnessed the highest global market share in 2022, with factors like improved efficacy and lower toxicity levels driving the segmental growth.

The antibiotic anticoccidials segment is expected to grow at the fastest CAGR due to increasing research and development activities.

By Animal Type

The poultry animal segment led the market in 2022, driven by poultry producers' adoption of anticoccidial drugs to improve bird productivity.

The companion animal segment is expected to witness a promising growth rate during the forecast period due to increasing pet ownership worldwide.

North America

The North American market accounted for the largest global market share in 2021, with a focus on advanced manufacturing techniques and pet healthcare.

Asia Pacific

The APAC market is forecasted to grow at a CAGR of 4.3% from 2022 to 2027, driven by the growing pet population and pharmaceutical industries in the region.

Europe

The European market is predicted to grow steadily due to increasing meat consumption and a sophisticated pet care industry in the region.

Latin America, Middle East, and Africa

The Latin American and MEA markets are projected to show steady growth, with Brazil, Mexico, and MEA countries driving market demand.

Key Players

Noteworthy companies in the global market include Bayer HealthCare, Zoetis, Elanco, Merial, and others.

Recent Developments

In 2022, Amlan International announced natural alternatives to anticoccidial drugs.

In 2020, Zoetis introduced implants for suckling calves, resulting in significant weight gain.